6-K
Report of Foreign Issuer
ASCENTAGE PHARMA GROUP INTERNATIONAL Filed Acc 0001213900-26-120260
INCLUSION OF LISAFTOCLAX ANNOUNCEMENT DATED NOVEMBER 16, 2026
- SHARE PURCHASE ANNOUNCEMENT DATED NOVEMBER 16, 2026
- CORPORATE DECK
From the SEC's structured data for this filing
Loading ea0312299-6k_ascentage.htm…